Rezolute is trading at $4.50, up 8.70% in pre-market, with no confirmed catalyst identified.
- Craig-Hallum upgraded Rezolute to Buy on September 29 and raised its price target to $7 from $4, citing anticipated Phase III topline data by year-end.
- Lake Street initiated coverage on September 30.
- No fresh October 1 company announcement explaining the move surfaced in the search. The connection to the analyst updates is unconfirmed, and the supplied broad-market picture is mixed.